Action 600976 JIANMIN PHARMACEUTICAL GROUP CO.,LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Jianmin Pharmaceutical Group Co.,Ltd.

Actions

600976

CNE000001HB7

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 30/04/2024 		Varia. 5j. Varia. 1 janv.
56,69 CNY +0,60 % Graphique intraday de Jianmin Pharmaceutical Group Co.,Ltd. +1,89 % -13,12 %
19/04 Jianmin Pharmaceutical Group Co. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
15/03 Jianmin Pharmaceutical Group Co. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Jianmin Pharma Gets Nod to Market Asthma Drug
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Jianmin Pharmaceutical’s Drugs Remain Covered by China’s National Medical Insurance
Jianmin Pharmaceutical Earmarks 132 Million Yuan to Expand China Factory; Shares Jump 8%
Jianmin Pharma Gets Nod to Market Drug For Children's Acute Bronchitis
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Jianmin Pharma Receives Nod to Market Oral Solution For Epilepsy Patients
Jianmin Pharmaceutical Group Co.,Ltd.(XSSC:600976) added to S&P Global BMI Index
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Jianmin Pharmaceutical Group Co.,Ltd. completed the acquisition of 6.13% stake in HeraMED Limited from Hua Li Pharmaceutical Group Co.,Ltd.
Jianmin Pharma Gets Nod to Market Atomoxetine Hydrochloride Oral Solution; Shares Drop 3%
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Jianmin Pharma's Liver, Stomach Disease Drug Included in China’s Medical Insurance Catalog
Jianmin Pharma to Buy 4.5% of Australia’s Hera Med for 8.4 Million Yuan
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Jianmin Pharmaceutical Group Co.,Ltd. intends to acquire Zhejiang Huafang Medical Care Co., Ltd from Holley Group Company Limited, Zhejiang Holley Investment Management Co., Ltd. and Suzhou Yuanyi Zhiyuan Equity Investment Partnership (Limited Partnership) for CNY 15.2 million.
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 600976
  4. Actualités Jianmin Pharmaceutical Group Co.,Ltd.
  5. Autres langues